ClotTriever Thrombectomy System Use-result Survey

ClotTriever Thrombectomy System Use-result Survey - ClotTriever Thrombectomy System Use-result Survey

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056909

Enrollment

100

Registered

2025-02-03

Start date

2025-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with deep vein thrombosis with acute severe symptoms (excluding post thrombotic syndrome)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All patients treated with this device

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
-Rate of Major Adverse Events [MAEs: All-cause mortality, Major bleeding, New symptomatic Pulmonary Embolism (PE) documented by Computed Tomography Pulmonary Angiography (CTPA), Rethrombosis of a Target Venous Segment] through 30 days after the index procedure. -Technical success (thrombus residual volume is assessed by the sites using pre- and post-procedure venography to evaluate the success of thrombus removal)	—

Measure

Time frame

-Rate of Major Adverse Events [MAEs: All-cause mortality, Major bleeding, New symptomatic Pulmonary Embolism (PE) documented by Computed Tomography Pulmonary Angiography (CTPA), Rethrombosis of a Target Venous Segment] through 30 days after the index procedure. -Technical success (thrombus residual volume is assessed by the sites using pre- and post-procedure venography to evaluate the success of thrombus removal)

—

Countries

Japan

Contacts

Public ContactSatoko Inoue

Vorpal Technologies K.K Regulatory Affairs

Satoko.Inoue@mcra.com+81-3-5544-8340

Outcome results